ADIPOQ and non-small cell lung carcinoma: In this connection, very recently, Nigro and coworkers reported a substantial reduction of total adiponectin levels in non-small-cell lung cancer (NSCLC) patients compared to healthy subjects, markedly affecting the high molecular weight [7].